Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call

Rhea-AI Summary

Endo (OTCQX: NDOI) has announced the rescheduling of its fourth quarter and full year 2024 financial results release to March 13, 2025, before market open. The company will host a conference call at 8:00 a.m. ET on the same day.

Investors can access the audio webcast through the Investor Relations section of Endo's website at investor.endo.com under Events & Presentations. Conference call participants can dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (international). Participants should join 10 minutes before the scheduled start time. A webcast replay will be available after the event.

News Market Reaction – NDOI

-1.40%

-1.40% Session move

In the trading session that priced this news, NDOI declined 1.40%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., March 10, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it has rescheduled the release of its fourth quarter and full year 2024 financial results to March 13, 2025, prior to market open. The Company will host a conference call on the same day at 8:00 a.m. ET.

The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.

About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-reschedules-release-of-fourth-quarter-and-full-year-2024-earnings-results-and-conference-call-302397491.html

SOURCE Endo, Inc.

FAQ

When will Endo (NDOI) release its Q4 and full year 2024 earnings?

Endo will release its Q4 and full year 2024 earnings on March 13, 2025, before market open.

How can investors access Endo's (NDOI) Q4 2024 earnings call?

Investors can join via webcast at investor.endo.com or dial 800-836-8184 (US/Canada) or 646-357-8785 (international).

What time is Endo's (NDOI) Q4 2024 earnings conference call?

The earnings conference call is scheduled for 8:00 a.m. ET on March 13, 2025.

Will there be a replay available for Endo's (NDOI) Q4 2024 earnings call?

Yes, a replay of the webcast will be available after the event.